siRNA compounds comprising terminal substitutions

Details for Australian Patent Application No. 2010324658 (hide)

Owner Quark Pharmaceuticals, Inc.

Inventors Avkin-Nachum, Sharon

Agent Cullens

Pub. Number AU-A-2010324658

PCT Pub. Number WO2011/066475

Priority 61/264,668 26.11.09 US; 61/295,721 17.01.10 US; 61/372,072 09.08.10 US

Filing date 25 November 2010

Wipo publication date 3 June 2011

International Classifications

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/066475 Priority application(s): WO2011/066475

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010324666-Control system for and method of controlling product delivery systems

2010324651-Vehicle route selection based on energy usage